Amoytop Biotech's Novel Chronic Hepatitis B Drug ALG-000184 Proposed for Breakthrough Therapy Designation
May 26, 2026 10:58
CST Updated
17:05
Amoytop Biotech
Developer and Producer of Recombinant Proteins and Their Long-Acting Modified Drugs